VDJ-031

N/A

Report date: 2025/06/09 17:26:44

Base Information

Drug NameVDJ-031
Drug Alias NameVDJ031VDJ-031
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor α modulatorsTumor necrosis factor superfamily member 15 modulators
TargetsTumor necrosis factor αTumor necrosis factor superfamily member 15
Therapy Area/IndicationsColitis, UlcerativeArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Vdjbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Vdjbio Co Ltd
Inactive CompaniesN/A
Active IndicationsColitis, UlcerativeArthritis, RheumatoidSpondylitis, Ankylosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A